UA-107708939-1
Your browser version is outdated. We recommend that you update your browser to the latest version.

Company Background:

MonTa Biosciences` technology has been developed at The Danish Technical University.

The team behind the technology is lead by CEO, PhD; Simon Skjøde Jensen, Professor; Thomas Lars Andresen, Associate Professor, Jonas Henriksen, Assistant Professor, Ladan Parhamifar and DVM. PhD; Anders E. Hansen.

The team have acquired strong competencies in Entrepreneurship, Business Development, IP and FTO analyses, Project and people management, development for clinical trial preparation and GMP production of nanoparticles.

MonTa Biosciences have achieved a Pre-Seed Grant from the Danish life science Investor Novo Seeds, and a grant from Copenhagen Spin out.

In June 2016 we have been awarded with a Grand Solutions grant from InnovationsFonden together with DTU and the Major University Hospital in Copenhagen and 3 other Companies. This grant is a strong support for development of the technology towards First-In Man studies.

In the fall of 2016 MonTa Biosciences was awarded a InnoBooster project from the Danish InnovationFund for development of novel immune stimulating compounds.

In January 2017 we have closet an Investment from one of the largest early-stage Danish Investors Pre-Seed Innovation, through the top 1 seed innovation accelerator Accelerace.